3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Leiomyoma
3
Neoplasms
2
Stroke
1
Sarcoma, Alveolar Soft Part
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peripheral Nervous System Diseases
1
Neuralgia
1
Myocardial Infarction
1
Liver Neoplasms
1
Liver Cirrhosis
1
Hot Flashes
1
Hemorrhage
1
Hand-Foot Syndrome
1
Colorectal Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Acupuncture Therapy
10
Exercise
7
Cryotherapy
6
Paclitaxel
5
Glutamine
5
Surveys and Questionnaires
3
Duloxetine Hydrochloride
3
Dexamethasone
3
Bortezomib
3
Acetylcysteine
3
pembrolizumab
2
enfortumab vedotin
2
Thioctic Acid
2
Tablets
2
Sodium Chloride
2
Saline Solution
2
Physical Therapy Modalities
2
Low-Level Light Therapy
2
Fish Oils
2
Fatty Acids, Omega-3
2
ziconotide
1
sagopilone
1
nicotinamide-beta-riboside
1
nabilone
1
glutamic acid diethyl ester
1
allantoicase
1
Yoga
1
XELOX
1
Vitamin D
1
Vitamin B Complex
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Peripheral Nervous System Diseases
×
Vitamin B 6
×
Clear all
NCT02795572
2019-07-05
CIPN
AHS Cancer Control Alberta
Phase 2
Terminated
13 enrolled